Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saskia Ting

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Elife|March 16, 2021
Increased longevity due to sexual activity in mole-rats is associated with transcriptional changes in the HPA stress axisArne Sahm, Matthias Platzer, Philipp Koch, et al.
Oncology Research and Treatment|June 20, 2017
Comprehensive Biomarker Analyses in Patients with Advanced or Metastatic Non-Small Cell Lung Cancer Prospectively Treated with the Polo-Like Kinase 1 Inhibitor BI2536Frank Breitenbuecher, Joachim von Pawel, Martin Sebastian, et al.
Oncotarget|May 17, 2017
Molecular dissection of effector mechanisms of RAS-mediated resistance to anti-EGFR antibody therapyStefan Kasper, Henning Reis, Sophie Ziegler, et al.
Pediatric Blood & Cancer|November 5, 2025
Melanoma of the Choroid and Ciliary Body in Children: Remission of Metastatic Melanoma of the Choroid After Treatment With Chemotherapy and Immune Checkpoint InhibitionPia Tüller, Tobias Kiefer, Leyla Jabbarli, et al.
Cancers|April 12, 2022
Multiparametric <sup>18</sup>F-FDG PET/MRI-Based Radiomics for Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast CancerLale Umutlu, Julian Kirchner, Nils-Martin Bruckmann, et al.
Human Pathology|October 15, 2024
Expression of the large amino acid transporter SLC7A5/LAT1 on immune cells is enhanced in primary sclerosing cholangitis-associated cholangiocarcinoma and correlates with poor prognosis in cholangiocarcinomaVittorio Branchi, Racha Hosni, Lukas Kiwitz, et al.
Journal of Cancer|August 27, 2014
Gene Expression Analysis of the 26S Proteasome Subunit PSMB4 Reveals Significant Upregulation, Different Expression and Association with Proliferation in Human Pulmonary Neuroendocrine TumoursFabian Dominik Mairinger, Robert Fred Henry Walter, Dirk Theegarten, et al.
Virchows Archiv : an International Journal of Pathology|June 26, 2012
Training increases concordance in classifying pulmonary adenocarcinomas according to the novel IASLC/ATS/ERS classificationArne Warth, Judith Cortis, Ludger Fink, et al.
Clinical Colorectal Cancer|August 2, 2020
Biweekly Cetuximab Plus FOLFOX6 as First-Line Therapy in Patients With RAS Wild-Type Metastatic Colorectal Cancer: The CEBIFOX TrialStefan Kasper, Johannes Meiler, Heike Knipp, et al.
Clinical Lung Cancer|April 11, 2018
MET Expression in Advanced Non-Small-Cell Lung Cancer: Effect on Clinical Outcomes of Chemotherapy, Targeted Therapy, and ImmunotherapyHenning Reis, Martin Metzenmacher, Moritz Goetz, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Elife|March 16, 2021
Increased longevity due to sexual activity in mole-rats is associated with transcriptional changes in the HPA stress axisArne Sahm, Matthias Platzer, Philipp Koch, et al.
Oncology Research and Treatment|June 20, 2017
Comprehensive Biomarker Analyses in Patients with Advanced or Metastatic Non-Small Cell Lung Cancer Prospectively Treated with the Polo-Like Kinase 1 Inhibitor BI2536Frank Breitenbuecher, Joachim von Pawel, Martin Sebastian, et al.
Oncotarget|May 17, 2017
Molecular dissection of effector mechanisms of RAS-mediated resistance to anti-EGFR antibody therapyStefan Kasper, Henning Reis, Sophie Ziegler, et al.
Pediatric Blood & Cancer|November 5, 2025
Melanoma of the Choroid and Ciliary Body in Children: Remission of Metastatic Melanoma of the Choroid After Treatment With Chemotherapy and Immune Checkpoint InhibitionPia Tüller, Tobias Kiefer, Leyla Jabbarli, et al.
Cancers|April 12, 2022
Multiparametric <sup>18</sup>F-FDG PET/MRI-Based Radiomics for Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast CancerLale Umutlu, Julian Kirchner, Nils-Martin Bruckmann, et al.
Human Pathology|October 15, 2024
Expression of the large amino acid transporter SLC7A5/LAT1 on immune cells is enhanced in primary sclerosing cholangitis-associated cholangiocarcinoma and correlates with poor prognosis in cholangiocarcinomaVittorio Branchi, Racha Hosni, Lukas Kiwitz, et al.
Journal of Cancer|August 27, 2014
Gene Expression Analysis of the 26S Proteasome Subunit PSMB4 Reveals Significant Upregulation, Different Expression and Association with Proliferation in Human Pulmonary Neuroendocrine TumoursFabian Dominik Mairinger, Robert Fred Henry Walter, Dirk Theegarten, et al.
Virchows Archiv : an International Journal of Pathology|June 26, 2012
Training increases concordance in classifying pulmonary adenocarcinomas according to the novel IASLC/ATS/ERS classificationArne Warth, Judith Cortis, Ludger Fink, et al.
Clinical Colorectal Cancer|August 2, 2020
Biweekly Cetuximab Plus FOLFOX6 as First-Line Therapy in Patients With RAS Wild-Type Metastatic Colorectal Cancer: The CEBIFOX TrialStefan Kasper, Johannes Meiler, Heike Knipp, et al.
Clinical Lung Cancer|April 11, 2018
MET Expression in Advanced Non-Small-Cell Lung Cancer: Effect on Clinical Outcomes of Chemotherapy, Targeted Therapy, and ImmunotherapyHenning Reis, Martin Metzenmacher, Moritz Goetz, et al.
Pageof 6